论文部分内容阅读
我科于1994年1月～1995年3月,使用精制蝮蛇抗栓酶(PA下简称抗栓酶)粉针剂(每支0.25μ,沈阳光大制药厂生产,批号930820)治疗动脉粥样硬化血栓形成性脑梗塞(以下简称脑梗塞)患者75例,疗效显著,并与同期低分子右旋糖酐治疗56例脑梗塞进行对比,现报道如下。 1 资料和方法 1.1 病例选择 全部为住院患者,经病史询问,神经系统检查及CT或MRI检查确诊,血小板计数在100×10~9/L以上,出凝血时间正常,无出血性疾病及严重肝、肾功能损害或多器官功能衰竭。病人随机分为两组,治疗组75例,其中男性56例,女性19例,年龄47～83
Our department in January 1994 ~ March 1995, the use of refined viper antithrombotic enzyme (PA antithrombotic enzyme) powder injection (each 0.25μ, Shenyang Everbright Pharmaceutical Factory production, batch number 930820) treatment of atherosclerosis Thrombotic cerebral infarction (hereinafter referred to as cerebral infarction) in 75 patients with significant effect, and with the same period low molecular dextran treatment of 56 cases of cerebral infarction were reported as follows. 1 Materials and Methods 1.1 All cases of hospitalized patients selected by medical history, neurological examination and CT or MRI examination confirmed platelet count in the 100 × 10 ~ 9 / L or more, the clotting time is normal, no bleeding disorders and severe liver , Renal impairment or multiple organ failure. Patients were randomly divided into two groups, the treatment group 75 cases, 56 males and 19 females, aged 47 to 83